The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Dr. Venkatesan most recently served as Chairman, President, and CEO of Angion Biomedica until its merger with Elicio Therapeutics in 2023. He currently serves as a Board Director at Elicio ...

Qatar’s VC (venture capital) funding reported a remarkable 135% year-on-year rise to an all-time high of QR115mn in 2024, ...

BOSTON—Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotech company currently trading near ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $407 from $402 and keeps a Sector Perform rating on the shares.

Singapore government sovereign wealth fund Temasek’s subsidiary, Vertex Ventures, is set to lead a $50-60 million funding ...

AI-driven enterprise tech startup SpotDraft has raised $54 Mn in its Series B funding round led by Vertex Growth and Trident ...

Global private equity and venture capital transaction value totaled $35.28 billion in January, down slightly compared with ...

Some of the most active venture capital firms in Latin America are planning to invest more in startups that offer loans and ...

Corporate Venture Capital (CVC) investment is an increasingly used strategic tool that enables large corporations to make ...

This latest initiative raises Hitachi’s total investment in CVC to $1 billion, reinforcing its commitment to identifying and ...